SEARCH

SEARCH BY CITATION

References

  • 1
    Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 121133.
  • 2
    Ambler RP. The structure of β-lactamases. Philos Trans R Soc London Series B Biol Sci 1980; 289: 32131.
  • 3
    Huovinen P, Huovinen S, Jacoby GA. Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother 1988; 32: 1346.
  • 4
    Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 55784.
  • 5
    Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J Clin Microbiol 1994; 32: 6916.
  • 6
    Molland ES, Sanders CC, Thomson KS. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? J Clin Microbiol 1998; 36: 25759.
  • 7
    Sanders CC, Thomson KS, Bradford PA. Problems with detection of β-lactam resistance among nonfastidious gram-negative bacilli. Infect Dis Clin North Am 1993; 7: 41125.
  • 8
    Naumovski L, Quinn JP, Miyashiro D et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992; 36: 19916.
  • 9
    Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33: 14516.
  • 10
    Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990; 18: 2948.
  • 11
    Bauernfeind A, Casellas JM, Goldberg M et al. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 1992; 20: 15863.
  • 12
    Karas JA, Pillay DG, Muckhart D, Sturm AW. Treatment failure due to extended-spectrum β-lactamase. J Antimicrob Chemother 1996; 37: 2034.
  • 13
    Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119: 3538.
  • 14
    Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 11824.
  • 15
    Rice LB, Yao JDC, Klimm K, Eliopoulos GM, Moellering RC Jr. Efficacy of different β-lactams against an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother 1991; 35: 12434.
  • 16
    Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 2(8554): 3026.
  • 17
    Jarlier V, Nicolas M-H, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 86778.
  • 18
    Sirot J. Detection of extended-spectrum plasmid-mediated β-lactamase by disk diffusion. Clin Microbiol Infect 1996; 2(suppl 1): S359.
  • 19
    Coudron PE, Molland ES, Sanders CC. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 1997; 35: 25937.
  • 20
    Emery CL & Weymouth LA. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35: 20617.
  • 21
    Carter MW, Oakton KJ, Warner M, Livermore DM. Detection of extended-spectrum β-lactamases in klebsiellae with the Oxoid combination disk method. J Clin Microbiol 2000; 38: 422832.
  • 22
    M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. J Antimicrob Chemother 2000; 45: 8815.
  • 23
    National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement. M100-S9. NCCLS: Wayne, PA: 1999.
  • 24
    Sanders CC, Barry AL, Washington JA et al. Detection of extended-spectrum β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. J Clin Microbiol 1996; 34: 29973001.
  • 25
    Jacoby GA & Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35: 1697704.
  • 26
    Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 3027.
  • 27
    Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 31517.
  • 28
    Sirot D, Sirot J, Labia R et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 1987; 20: 32334.
  • 29
    Rice LB, Willey SH, Papanicolaou GA et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990; 34: 21939.
  • 30
    Urban C, Meyer KS, Mariano N et al. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 1994; 38: 3925.
  • 31
    Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob Agents Chemother 1994; 38: 7616.
  • 32
    Arakawa Y, Ohta M, Kido N et al. Chromosomal β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics. Antimicrob Agents Chemother 1989; 33: 6370.
  • 33
    Fournier B & Roy PH. Variability of chromosomally encoded β-lactamases from Klebsiella oxytoca. Antimicrob Agents Chemother 1997; 41: 16418.
  • 34
    Rossolini GM, Franceschini N, Lauretti L et al. Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaACME) encoding an extended-spectrum class A β-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases. Antimicrob Agents Chemother 1999; 43: 21939.
  • 35
    Bellais S, Poirel L, Naas T, Girlich D, Nordmann P. Genetic-biochemical analysis and distribution of the Ambler class A β-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium). meningosepticum. Antimicrob Agents Chemother 2000; 44: 19.
  • 36
    Rogers MB, Parker AC, Smith CJ. Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A β-lactamases. Antimicrob Agents Chemother 1993; 37: 2391400.
  • 37
    Smith CJ, Bennett TK, Parker AC. Molecular and genetic analysis of the Bacteroides uniformis cephalosporinase gene cblA, encoding the species-specific β-lactamase. Antimicrob Agents Chemother 1994; 38: 171115.
  • 38
    Saino Y, Inoue M, Mitsuhashi S. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN 12873. Antimicrob Agents Chemother 1984; 25: 3625.
  • 39
    Walsh TR, MacGowen AP, Bennett PM. Sequence analysis and enzyme kinetics of the L2 β-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997; 41: 14604.
  • 40
    Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob Agents Chemother 1996; 40: 50913.
  • 41
    Oliver A, Pérez-Díaz JC, Coque TM, Baquero F, Cantón R. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother 2001; 45: 61620.
  • 42
    Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother 1999; 43: 57381.
  • 43
    Silva J, Aguilar C, Ayala G et al. TLA-1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrob Agents Chemother 2000; 44: 9971003.
  • 44
    Bonnet R, Sampaio JLM, Chanal C et al. A novel class A extended-spectrum β-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob Agents Chemother 2000; 44: 30618.
  • 45
    Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000; 44: 62232.
  • 46
    Sougakoff W, Goussard S, Courvalin P. The TEM-3 β-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiol Lett 1988; 56: 3438.
  • 47
    Barthélémy M, Péduzzi J, Yaghlane HB, Labia R. Single amino acid substitution between SHV-1 β-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme. FEBS Lett 1988; 231: 21720.
  • 48
    Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24(suppl 1): S1945.
  • 49
    Hæggman S, Löfdahl S, Burman LG. An allelic variant of the chromosomal gene for class A β-lactamase K2, specific for Klebsiella pneumoniae is the ancestor of SHV-1. Antimicrob Agents Chemother 1997; 41: 27059.
  • 50
    Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000; 14: 13742.DOI: 10.1016/s0924-8579(99)00165-x
  • 51
    Péduzzi J, Farzaneh S, Reynaud A, Barthélémy M, Labia R. Characterization and amino acid sequence analysis of a new oxyimino cephalosporin-hydrolyzing class A beta-lactamase from Serratia fonticola CUV. Biochim Biophys Acta 1997; 1341: 5870.
  • 52
    Knox JR. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob Agents Chemother 1995; 39: 2593601.
  • 53
    Blázquez J, Negri M-C, Morosini M-I, Gómez-Gómez JM, Baquero F. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type β-lactamases. Antimicrob Agents Chemother 1998; 42: 10424.
  • 54
    Huang W & Palzkill T. A natural polymorphism in β-lactamase is a global suppressor. Proc Natl Acad Sci USA 1997; 94: 88016.DOI: 10.1073/pnas.94.16.8801
  • 55
    Prinarakis EE, Miriagou V, Tzelepi E, Gazouli M, Tzouvelekis LS. Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob Agents Chemother 1997; 41: 83840.
  • 56
    Sirot D, Recule C, Chaibi EB et al. A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob Agents Chemother 1997; 41: 13225.
  • 57
    Fiett J, Palucha A, Miaczyñska B et al. A novel complex mutant β-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum β-lactamase-producing klebsiellae. Antimicrob Agents Chemother 2000; 44: 1499505.
  • 58
    Perilli M, Felici A, Franceschini N et al. Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain. Antimicrob Agents Chemother 1997; 41: 237482.
  • 59
    Arpin C, Labia R, Andre C, Frigo C, El-Harrif Z, Quentin C. SHV-16, a β-lactamase with a pentapeptide duplication in the omega loop. Antimicrob Agents Chemother 2001; 45: 24805.
  • 60
    Poyart C, Mugnier P, Quesne G, Berche P, Trieu-Cuot P. A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother 1998; 42: 10813.
  • 61
    Sougakoff W, Petit A, Goussard S, Sirot D, Bure A, Courvalin P. Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad spectrum β-lactamases TEM-4 and TEM-5 in Enterobacteriaceae. Gene 1989; 78: 33948.
  • 62
    Leflon-Guibout V, Heym B, Nicolas-Chanoine M-H. Updated sequence information and proposed nomenclature for blaTEM genes and their promoters. Antimicrob Agents Chemother 2000; 44: 32324.
  • 63
    Ambler RP & Scott GK. Partial amino acid sequence of penicillinase coded by Escherichia coli plasmid R6K. Proc Natl Acad Sci USA 1978; 75: 37326.
  • 64
    Nüesch-Inderbinen MT, Kayser FH, Hächler H. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 1997; 41: 9439.
  • 65
    Mercier J & Levesque RC. Cloning of SHV-2, OHIO-1, and OXA-6 β-lactamases and cloning and sequencing of SHV-1 β-lactamase. Antimicrob Agents Chemother 1990; 34: 157783.
  • 66
    Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 51420.
  • 67
    Chanal C, Sirot D, Malaure H, Poupart M-C, Sirot J. Sequences of CAZ-3 and CTX-2 extended-spectrum β-lactamase genes. Antimicrob Agents Chemother 1994; 38: 24523.
  • 68
    Soilleux MJ, Morand AM, Arlet GJ, Scavizzi MR, Labia R. Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrob Agents Chemother 1996; 40: 10279.
  • 69
    Hibbert-Rogers LCF, Heritage J, Todd N, Hawkey PM. Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity. J Antimicrob Chemother 1994; 33: 70720.
  • 70
    Heritage J, Hawkey PM, Todd N, Lewis IJ. Transposition of the gene encoding a TEM-12 extended-spectrum β-lactamase. Antimicrob Agents Chemother 1992; 36: 19816.
  • 71
    Arlet G, Brami GG, Décre D et al. Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol Lett 1995; 134: 2038.DOI: 10.1016/0378-1097(95)00405-8
  • 72
    Arlet G, Rouveau M, Fournier G, Philippon A. Sequences of the genes for the TEM-20, TEM-21, TEM-22 and TEM-29 extended-spectrum β-lactamases. Antimicrob Agents Chemother 1999; 43: 96971.
  • 73
    Danel F, Hall LMC, Gur D, Livermore DM. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995; 39: 18814.
  • 74
    Yagi T, Kurokawa H, Shibata N, Shibayama K, Arakawa Y. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 2000; 184: 536.
  • 75
    Ishii Y, Ohno A, Taguchi H, Imajo S, Ishiguro M, Matsuzawa H. Cloning and sequence of the gene encoding a cefitaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 1995; 39: 226975.
  • 76
    Ma L, Ishii Y, Ishiguro M, Matsuzawa H, Yamaguchi K. Cloning and sequencing of the gene encoding Toho-2, a class A β-lactamase preferentially inhibited by tazobactam. Antimicrob Agents Chemother 1998; 42: 11816.
  • 77
    Ishii Y, Galleni M, Ma L, Yamaguchi K, Frère J-M. Cloning, DNA sequence and enzymatic properties of Toho-3 as a new extended-spectrum β-lactamase [Abstract C-1474]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 98.
  • 78
    Palucha A, Mikiewicz B, Hryniewicz W, Gniadkowski M. Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 1999; 44: 48999.DOI: 10.1093/jac/44.4.489
  • 79
    Blázquez J, Morosini M-I, Negri M-C, Baquero F. Selection of naturally occurring extended-spectrum TEM β-lactamase variants by fluctuating β-lactam pressure. Antimicrob Agents Chemother 2000; 44: 21824.
  • 80
    Chanal-Claris C, Sirot D, Bret L, Chatron P, Labia R, Sirot J. Novel extended-spectrum-type β-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalotin. Antimicrob Agents Chemother 1997; 41: 71516.
  • 81
    Cantu C, Huang W, Palzkill T. Selection and characterization of amino acid substitutions at residues 237–240 of TEM-1 β-lactamase with altered substrate specificity for aztreonam and ceftazidime. J Biol Chem 1996; 271: 2253845.
  • 82
    Palzkill T, Le Q, Venkatachalam KV, LaRocco M, Ocera H. Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of β-lactamase. Mol Microbiol 1994; 12: 21729.
  • 83
    Petrosino JF & Palzkill T. Systematic mutagenesis of the active site omega loop of TEM-1 β-lactamase. J Bacteriol 1996; 178: 18218.
  • 84
    Venkatachalam KV, Huang W, LaRocco M, Palzkill T. Characterization of TEM-1 β-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime. J Biol Chem 1994; 269: 2344450.
  • 85
    Galas MF, Rapoport MJ, Pasteran FG et al. High distribution of CTX-M-2 β-lactamase among Klebsiella spp. isolates in an Argenitinean extended-spectrum β-lactamase (ESBLA) surveillance program [Abstract C2-1474]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Fransisco, CA. Washington, DC: American Society for Microbiology, 1999: 165.
  • 86
    Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, Gniadkowski M. A countrywide spread of CTX-M-3 extended-spectrum β-lactamase (ESBL)-producing microorganisms of the family Enterobacteriaceae in Poland. Submitted.
  • 87
    Kurokawa H, Yagi T, Shibata N, Shibayama K, Kamachi K, Arakawa Y. A new SHV-derived extended-spectrum β-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the Ω-loop. Antimicrob Agents Chemother 2000; 44: 17257.
  • 88
    Arlet G, Rouveau M, Philippon A. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum β-lactamase. FEMS Microbiol Lett 1997; 152: 1637.DOI: 10.1016/s0378-1097(97)00196-1
  • 89
    Rasheed JK, Jay C, Metchcock B et al. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997; 41: 64753.
  • 90
    Mabilat C, Goussard S, Sougakoff W, Spencer RC, Courvalin P. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid 1990; 23: 18.
  • 91
    Goussard S, Sougakoff W, Mabilat C, Bauernfeind A, Courvalin P. An IS1-like element is responsible for high-level synthesis of extended-spectrum β-lactamase TEM-6 in Enterobacteriaceae. J Gen Microbiol 1991; 137: 26817.
  • 92
    French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996; 34: 35863.
  • 93
    Palucha A, Mikiewicz B, Gniadkowski M. Diversification of Echerichia coli expressing an SHV-type extended-spectrum β-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1999; 43: 3936.
  • 94
    Essack SY, Hall LCM, Pillay DG, McFyden ML, Livermore DM. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother 2001; 45: 8895.
  • 95
    Pasteran F & Galas M. Extended-spectrum β-lactamase (ESBL) among AMP-C producer enterobacteria in Argentina: detection by the Vitek ESBL test [Abstract D-1607]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 153.
  • 96
    Martínez- Martínez L, Hernández-Allés S, Albertí S, Tomás JM, Benedi VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and extended-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 3428.
  • 97
    Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 63548.
  • 98
    Pangon B, Bizet C, Buré A et al. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumonie producing a TEM-3 β-lactamase. J Infect Dis 1989; 159: 10056.
  • 99
    De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J, the French Study Group. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. Antimicrob Agents Chemother 2000; 44: 31779.
  • 100
    Bell JM & Turnidge JD. Emergence of extended-spectrum β-lactamases in Enterobacter cloacae from the SENTRY Surveillance Program for the Western Pacific and South Africa (WP+), 1998–9 [Abstract C-1988]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 119.
  • 101
    Arpin C, Coze C, Rogues AM, Gachie JP, Bebear C, Quentin C. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol 1996; 34: 21639.
  • 102
    Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazmierczak A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae. J Clin Microbiol 1996; 34: 769.
  • 103
    Winokur PL, Cantón R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32(suppl 2): S94103.DOI: 10.1086/320182
  • 104
    Sirot D, De Champs C, Chanal C et al. Translocation of antibiotic resistance determinants including an extended-spectrum β-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 1991; 35: 157681.
  • 105
    Villa L, Pezzella C, Tosini F, Visca P, Petrucca A, Carattoli A. Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum β-lactamase gene and a class 1 integron. Antimicrob Agents Chemother 2000; 44: 291114.
  • 106
    Marchandin H, Jean-Pierre H, De Champs C et al. Production of a TEM-24 plasmid-mediated extended-spectrum β-lactamase by a clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44: 21316.
  • 107
    Marchandin H, Carriere C, Sirot D, Jean-Pierre H, Darbas H. TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient. Antimicrob Agents Chemother 1999; 43: 206973.
  • 108
    Bush K. Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis 1996; 15: 3614.
  • 109
    Itokazu G, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a National Postmarketing Surveillance Program. Clin Infect Dis 1996; 23: 77984.
  • 110
    Sader HS, Gales AC, Casellas JM et al. Comparison of the antimicrobial susceptibilities of nosocomial bacteria among Latin American countries [Abstract C-1026]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 85.
  • 111
    Warren JR, Farmer JJ III, Dewhirst FE et al. Outbreak of nosocomial infections due to extended-spectrum β-lactamase-producing strains of Enteric Group 137, a new member of the family Enterobactariaceae closely related to Citrobacter farmeri and Citrobacter amalonaticus. J Clin Microbiol 2000; 38: 394652.
  • 112
    Sirot DL, Goldstein FW, Soussy CJ et al. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother 1992; 36: 167781.
  • 113
    Shannon K & French G. Multiple-antibiotic-resistant salmonella. Lancet 1998; 352: 4901.
  • 114
    Bradford PA, Yang Y, Sahm D, Grope I, Gardovska D, Storch G. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother 1998; 42: 19804.
  • 115
    Tassios PT, Gazouli M, Tzelepi E et al. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J Clin Microbiol 1999; 37: 37747.
  • 116
    Nordmann P & Guibert M. Extended-spectrum β-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998; 42: 12831.DOI: 10.1093/jac/42.2.128
  • 117
    Danel F, Hall LMC, Duke B, Gur D, Livermore DM. OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase isolated from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 13626.
  • 118
    Poirel L, Girlich D, Naas T, Nordmann P. OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Antimicrob Agents Chemother 2001; 45: 44753.
  • 119
    Nordmann P & Naas T. Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with other class A β-lactamases. Antimicrob Agents Chemother 1994; 38: 10414.
  • 120
    Mugnier P, Dubrous P, Casin I, Arlet G, Collatz EA. TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40: 248893.
  • 121
    Dubois V, Arpin C, Noury P, Andre C, Frigo C, Quentin C. Clinical strains of Pseudomonas aeruginosa producing a TEM-21 extended β-lactamase isolated from patients of a nursing home [Abstract C-2009]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 124.
  • 122
    Naas T, Philippon L, Poirel L, Ronco E, Nordmann P. An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 12814.
  • 123
    Hawkey PM, Chanawong A, Lulitanond A et al. SHV-5 extended-spectrum β-lactamase from Pseudomonas aeruginosa in Thailand [Abstract C-174a]. In. Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Washington, DC: American Society for Microbiology, 1998: 119.
  • 124
    Vahaboglu H, Ozturk R, Aygun G et al. Widespread detection of PER-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997; 41: 22659.
  • 125
    Denton M, M'Zali FH, Wilcox MH et al. Outbreak of PER-1-like-producing Acinetobacter baumannii occurring on a neurosurgery intensive care unit [Abstract C2-1486]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC: American Society for Microbiology, 1999: 169.
  • 126
    Pereira M, Perilli M, Mantengoli E et al. PER-1 extended-spectrum β-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy. Microb Drug Resist 2000; 6: 8590.
  • 127
    Rosenau A, Cattier B, Gousset N, Harriau P, Philippon A, Quentin R. Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 β-lactamase in the phylum Flavobacter-Bacteroides. Antimicrob Agents Chemother 2000; 44: 760.
  • 128
    M'Zali FH, Heritage J, Aitameur A, Hawkey PM. β-Lactam resistance mediated by SHV-12 extended-spectrum β-lactamases in Burkholderia cepacia recovered from Algeria [Abstract C-170]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Washington, DC: American Society for Microbiology, 1998: 118.
  • 129
    Rahal JJ. Extended-spectrum β-lactamases: how big is the problem? Clin Microbiol Infect 2000; 6(suppl 2): 26.
  • 130
    Bradford PA, Urban C, Jaiswal A et al. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother 1995; 39: 899905.
  • 131
    Rasmussen BA, Bradford PA, Quinn JP, Wiener J, Weinstein RA, Bush K. Genetically diverse ceftazidime resistant isolates from a single center: biochemical and genetic characterization of TEM-10 β-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother 1993; 37: 198992.
  • 132
    Fey PD, Safranek TJ, Rupp ME et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 2000; 342: 12801.
  • 133
    Winokur PL, Brueggemann A, DeSalvo DL et al. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrob Agents Chemother 2000; 44: 277783.
  • 134
    Venezia RA, Scarano FJ, Preston KE et al. Molecular epidemiology of an SHV-5 extended-spectrum β-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995; 21: 91523.
  • 135
    Gniadkowski M, Palucha A, Grzesiowski P, Hryniewicz W. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw: clonal spread of the TEM-47 extended-spectrum β-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene. Antimicrob Agents Chemother 1998; 42: 307985.
  • 136
    Odeh R, Kelkar S, Nathan C et al. Molecular epidemiology of extended-spectrum β-lactamase (ESBL) producing Escherichia coli (EC) and Klebsiella pneumoniae (KP) in a long term care facility (LTCF) [Abstract C-2001]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 122.
  • 137
    Peixe LV, Sousa JCF, Perez-Diaz J-C, Baquero FA. blaTEM-1b-derived TEM-6 β-lactamase: a case of convergent evolution. Antimicrob Agents Chemother 1997; 41: 1206.
  • 138
    Shannon KP, King A, Phillips I, Nicolas M-H, Philippon A. Importation of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom. J Antimicrob Chemother 1990; 25: 34351.
  • 139
    Bernard H, Tancrède C, Livrelli V, Morand A, Barthélémy M, Labia R. A novel plasmid-mediated extended-spectrum β-lactamase not derived from TEM- or SHV-type enzymes. J Antimicrob Chemother 1992; 29: 5902.
  • 140
    Arlet G, Rouveau M, Casin I, Bouvet PJ, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994; 32: 25538.
  • 141
    Bosi C, Davin-Regli A, Bornet C, Mallea M, Pages JM, Bollet C. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol 1999; 37: 21659.
  • 142
    Gouby A, Neuwirth C, Bourg G et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994; 32: 3015.
  • 143
    Peña C, Pujol M, Ardanuy C et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 538.
  • 144
    Kitzis MD, Billot-Klein D, Goldstein FW et al. Dissemination of the novel plasmid-mediated β-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by β-lactamase inhibitors. Antimicrob Agents Chemother 1988; 32: 914.
  • 145
    Mabilat C, Lourencao-Vital J, Goussard S, Courvalin P. A new example of physical linkage between Tn1 and Tn21: the antibiotic multiple-resistance region of plasmid pCFF04 encoding extended-spectrum β-lactamase. Mol Gen Genet 1992; 235: 11321.
  • 146
    Babini GS, Hall LMC, Yuan M, Livermore DM. Changes in the epidemiology of Klebsiella spp. ESBL-producers collected from intensive care units in 1994 and 1997–98 [Abstract C-2000]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 122.
  • 147
    Rogues AM, Boulard G, Allery A et al. Thermometers as a vehicle for transmission of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. J Hosp Infect 2000; 45: 767.
  • 148
    Gaillot O, Maruéjouls C, Abachin É et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998; 36: 135760.
  • 149
    Preston KE, Graffunder EM, Venezia RA. Tracking an SHV-5-encoding plasmid family in clinical isolates using plasmid-derived gene probes [Abstract C-2002]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 123.
  • 150
    Coque MT, Oliver A, Baquero F, Pérez-Díaz JC, Cantón R. A great clonal and plasmid diversity of ESBL Klebsiella pneumoniae in a Spanish hospital over a decade [Abstract C-1996]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 121.
  • 151
    Chanal CM, Sirot DL, Petit A et al. Multiplicity of TEM-derived β-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob Agents Chemother 1989; 33: 191520.
  • 152
    Livermore DM & Yuan M. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 40924.
  • 153
    Babini GS, Yuan M, Livermore DM. Prevalence of ESBLs and other potent β-lactamases among Klebsiella spp. in European ICUs in 1994 and 1997/8 [Abstract C2-1484]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Fransisco, CA. Washington, DC: American Society for Microbiology, 1999: 168.
  • 154
    Lee K, Chang C, Kim EC et al. Nationwide spread of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Korea [Abstract C-1994]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 121.
  • 155
    Petit A, Gerbaud G, Sirot D, Courvalin P, Sirot J. Molecular epidemiology of TEM-3 (CTX-1) β-lactamase. Antimicrob Agents Chemother 1990; 34: 21924.
  • 156
    Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A. Epidemiology of extended-spectrum β-lactamases. Infection 1989; 17: 34754.
  • 157
    Gutmann L, Ferre B, Goldstein FW et al. SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989; 33: 9516.
  • 158
    Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 β-lactamase among hospitalized patients. Infection 1993; 21: 1822.
  • 159
    Mulgrave L & Attwood PV. Characterization of an SHV-5 related extended broad-spectrum β-lactamase in Enterobacteriaceae from Western Australia. Pathology 1993; 25: 715.
  • 160
    Marchese A, Arlet G, Schito GC, Lagrange PH, Philippon A. Detection of SHV-5 extended-spectrum β-lactamase in Klebsiella pneumoniae strains isolates in Italy. Eur J Clin Microbiol Infect Dis 1996; 15: 2458.
  • 161
    Prodinger WM, Fille M, Bauernfeind A et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34: 5648.
  • 162
    Bedenic B & Zagar Z. Extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia. J Chemother 1998; 10: 44959.
  • 163
    Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998; 42: 13504.
  • 164
    Szabó D, Filetóth Z, Szentandrássy J et al. Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase in the premature intensive care unit of a Hungarian hospital. J Clin Microbiol 1999; 37: 41679.
  • 165
    Yan J-J, Wu S-M, Tsai S-H, Wu J-J, Su I-J. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 2000; 44: 143842.